MedCity News April 1, 2025
The conditions the biopharma companies target include sepsis, antimicrobial resistance, and acute infectious conjunctivitis.
The finalists for the biopharma track of INVEST Pitch Perfect have been selected. At the INVEST Pitch Perfect boutique healthcare investor conference, six biopharma companies will present their approaches to infectious disease, the track theme this year. INVEST is scheduled for May 20-21 at the Willis Tower in Chicago. Investors serving as the biopharma track judges include: Ryan Kole, partner with V Capital; Matt Martin, Pathway Bioventures partner; and Michael Schultz, senior director of venture operations at Portal Innovation.
To view the full agenda and register click here.
Here is a preview of the biopharma track finalists presenting at INVEST Pitch Perfect.
Canurta Therapeutics Antimicrobial...
Today's Sponsors
Today's Sponsor